Skip to main content
  • English
    • Nederlands
    • Français
Home
If you have been supplied with a PIN Code, you may enter it here.
  • Sign In
  • Home
  • Therapeutic areas
    • Cardiology
      • Pathology
      • News
      • Events
    • Dermatology
      • Pathology
      • News
      • Training
      • Events
    • Hematology
      • Pathology
      • Products
    • Neurology
      • Pathology
      • Events
    • Oncology
      • News
      • Events
    • Ophthalmology
      • Pathology
      • Training
      • Events
    • Respiratory
      • Pathology
      • Events
    • Rheumatology
      • News
  • Products
    • Auto-inflammatory disease
      • Ilaris®
    • Cardiology
      • Entresto®
      • Leqvio®
    • Dermatology
      • Cosentyx®
      • Xolair®
    • Hematology
      • Exjade®
      • Jakavi®
      • Kymriah® Info
      • Revolade®
      • Rydapt® AML
    • Neurology
      • Aimovig®
      • Gilenya®
    • Oncology
      • ESMO 2021
      • Kisqali
      • Tafinlar® + Mekinist®
    • Ophthalmology
      • Beovu®
      • Lucentis®
      • Luxturna®
    • Respiratory
      • Xolair®
    • Rheumatology
    • Reimbursement
      • Reimbursement documents
  • Patient
    • Auto-inflammatory disease
      • Familial Mediterranean Fever (FMF)
    • Cardiology
      • Heart Failure
    • Dermatology
      • Psoriasis
    • Hematology
      • Myelofibrosis / Polycythaemia Vera
    • Neurology
      • SPMS
    • Oncology
      • Breast Cancer
      • Melanoma
    • Ophthalmology
      • AMD / DME / OVR
    • Respiratory
      • Asthma
    • Rheumatology
      • SpA / AS / PsA / nr-axSpA
  • Training & Events
  • Materials
  • Contact

Popular Search

  • improved
  • improving
  • aimovig
  • migration
  • migraine

Recent News

Tom Detroyer
test ICS
test ICS
Search
  1. Privacy Policy

Privacy Policy

 

Privacy Policy - Dutch Privacy Policy - French

 

×

Ask Speakers

Contact


Novartis Pharma NV/SA: + 32 (0)2 246 16 11

 

Medical questions:

Click here

 
 

In case of an adverse event:

[email protected]
Phone number 24/h:
Bel: 0800 94 368
Lux: + 32 475 319 792
 

Subscribe to Novartis

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
Sitemap
Cookie Settings
©2022 Novartis Belgium and Luxembourg
  • Terms of use
  • Privacy Policy
  • About cookies
This website is intended for health care professionals in Belgium and Luxembourg